Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke: a 10-year systematic review of the literature
- PMID: 30415226
- DOI: 10.1136/neurintsurg-2018-014239
Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke: a 10-year systematic review of the literature
Abstract
Background: Accurate assessment of the prevalence of large vessel occlusion (LVO) in patients presenting with acute ischemic stroke (AIS) is critical for optimal resource allocation in neurovascular intervention.
Objective: To perform a systematic review of the literature in order to identify the proportion of patients with AIS presenting with LVO on image analysis.
Methods: A systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines in order to identify studies reporting LVO rates for patients presenting with AIS. Studies that included patients younger than 18 years, were non-clinical, or did not report LVO rates in the context of a consecutive AIS series were excluded. Characteristics regarding presentation, diagnosis, and LVO classification were recorded for each paper.
Results: Sixteen studies, spanning a total of 11 763 patients assessed for stroke, were included in the qualitative synthesis. The majority (10/16) of articles reported LVO rates exceeding 30% in patients presenting with AIS. There was substantial variability in the LVO definitions used, with nine unique classification schemes among the 16 studies. The mean prevalence of LVO was 31.1% across all studies, and 29.3% when weighted by the number of patients included in each study.
Conclusions: Despite the wide variability in LVO classification, the majority of studies in the last 10 years report a high prevalence of LVO in patients presenting with AIS. These rates of LVO may have implications for the volume of patients with AIS who may benefit from endovascular therapy.
Keywords: statistics; stroke.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: KC is employed at Imperative Care, which is developing products for stroke treatment. JM is a consultant for The Stroke Project, Rebound Therapeutics, Viseon, Pulsar, Cerebrotech, Endostream, Vastrax; and an investor in Cerebrotech, The Stroke Project, Endostream, Apama, Rebound, Viseon, Neurvana, Cardinal Consulting, BlinkTBI, Serenity, NeuroTechnology Investors.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical